ATRICURE INC (ATRC) Stock Price, Quote, News and Overview
NASDAQ:ATRC - Nasdaq - US04963C2098 - Common Stock - Currency: USD
ATRC Quote, Performance and Key Statistics
38.39
-0.77 (-1.97%)
The current stock price of ATRC is 38.39 USD. In the past month the price decreased by -4.9%. In the past year, price increased by 14.39%.
ATRC Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
| ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
| SYK | STRYKER CORP | 31.4 | 145.92B | ||
| MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
| BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
| IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
| DXCM | DEXCOM INC | 53.81 | 34.68B | ||
| RMD | RESMED INC | 26.21 | 34.03B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Related stock screener links
About ATRC
Company Profile
AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. The company is headquartered in Mason, Ohio and currently employs 1,200 full-time employees. The company went IPO on 2005-08-05. The firm's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The firm's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Company Info
ATRICURE INC
7555 Innovation Way
Mason OHIO 45040 US
CEO: Michael H. Carrel
Employees: 1200
Company Website: https://www.atricure.com
Investor Relations: https://ir.atricure.com
Phone: 15137554100
ATRICURE INC / ATRC FAQ
What is the stock price of ATRICURE INC today?
The current stock price of ATRC is 38.39 USD. The price decreased by -1.97% in the last trading session.
What is the ticker symbol for ATRICURE INC stock?
The exchange symbol of ATRICURE INC is ATRC and it is listed on the Nasdaq exchange.
On which exchange is ATRC stock listed?
ATRC stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ATRICURE INC stock?
15 analysts have analysed ATRC and the average price target is 55.72 USD. This implies a price increase of 45.14% is expected in the next year compared to the current price of 38.39. Check the ATRICURE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ATRICURE INC worth?
ATRICURE INC (ATRC) has a market capitalization of 1.87B USD. This makes ATRC a Small Cap stock.
How many employees does ATRICURE INC have?
ATRICURE INC (ATRC) currently has 1200 employees.
What are the support and resistance levels for ATRICURE INC (ATRC) stock?
ATRICURE INC (ATRC) has a support level at 38.38 and a resistance level at 40.22. Check the full technical report for a detailed analysis of ATRC support and resistance levels.
Is ATRICURE INC (ATRC) expected to grow?
The Revenue of ATRICURE INC (ATRC) is expected to grow by 12.82% in the next year. Check the estimates tab for more information on the ATRC EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ATRICURE INC (ATRC) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ATRC, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ATRC, evaluating the profitability, health, valuation and growth aspects
- ATRICURE INC (ATRC) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ATRICURE INC (ATRC) Sales and EPS estimates to see what analysts future expectations are.
- ATRICURE INC (ATRC) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ATRICURE INC (ATRC) Insider and Institutional Ownership to learn about the owners and their transactions.
- ATRICURE INC (ATRC) Stock Chart to make your own analysis
- ATRICURE INC (ATRC) Latest news and press-releases to stay up to date.
Does ATRICURE INC (ATRC) stock pay dividends?
ATRC does not pay a dividend.
When does ATRICURE INC (ATRC) report earnings?
ATRICURE INC (ATRC) will report earnings on 2025-04-29, after the market close.
What is the Price/Earnings (PE) ratio of ATRICURE INC (ATRC)?
ATRICURE INC (ATRC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.7).
What is the Short Interest ratio of ATRICURE INC (ATRC) stock?
The outstanding short interest for ATRICURE INC (ATRC) is 2.48% of its float. Check the ownership tab for more information on the ATRC short interest.
ATRC Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to ATRC. When comparing the yearly performance of all stocks, ATRC is one of the better performing stocks in the market, outperforming 77.71% of all stocks.
ATRC Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to ATRC. The financial health of ATRC is average, but there are quite some concerns on its profitability.
ATRC Financial Highlights
Over the last trailing twelve months ATRC reported a non-GAAP Earnings per Share(EPS) of -0.7. The EPS increased by 6.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -7.34% | ||
| ROE | -9.7% | ||
| Debt/Equity | 0.15 |
ATRC Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 85% to ATRC. The Buy consensus is the average rating of analysts ratings from 15 analysts.
For the next year, analysts expect an EPS growth of 11.03% and a revenue growth 12.82% for ATRC